Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ABSORB: Final Outcomes With the Absorb Bioresorbable Vascular Scaffold
Author(s): David Power Added: 1 year ago
Outcomes investigating the Absorb bioresorbable vascular scaffold (BVS) in patients undergoing percutaneous coronary intervention showed more adverse ischaemic events through 5 years compared with cobalt-chromium everolimus-eluting stents. However, the period of excess risk ended at 3 years.In this short interview, Dr David Power (Mount Sinai Hospital, New York, US) discusses the final report… View more

Intervention

Prevention & Chronic Conditions
The MOTIV Trial: 3-Year Results
Author(s): Added: 1 year ago
Three-year findings from a sirolimus-eluting bioresorbable vascular scaffold (BVS) for the treatment of infrapopliteal lesions show great primary patency rates in lesions with an average lesion length of 3cm and a high rate of freedom from clinically-driven target lesion revascularisation.Dr Michel Bosiers (Inselspital Bern, Bern, CH) joins us to discuss the prospective, multicentre, single-arm,… View more

Vascular Disease and Surgery
TCT 25: LIFE-BTK: The Esprit™ BTK Drug-Eluting Resorbable Scaffold for Infrapopliteal Lesions
Author(s): Sahil Parikh Added: 6 months ago
TCT 2025 - Three-year findings from LIFE-BTK show the Esprit™ BTK scaffold is a durable and effective treatment option for patients with CLTI.Dr Sahil Parikh (Columbia University Vagelos College of Physicians & Surgeons, New York, US) joins us to share the three-year findings from LIFE-BTK (NCT04227899). The randomized controlled trial aimed to evaluate the safety and efficacy of the Esprit™ BTK… View more

Intervention

Vascular Disease and Surgery
AF Symposium 26: STYLE AF Update
Author(s): Roland R Tilz Added: 3 months ago
AF Symposium 2026 - Prof Roland Tilz (University Heart Center Lübeck, DE) presents updated findings from the STYLE AF study evaluating vascular closure strategies in patients undergoing atrial fibrillation ablation, with implications for procedural efficiency and same-day discharge protocols.Results demonstrated clear superiority of the vascular closure device across multiple clinically relevant… View more

Electrophysiology & Arrhythmia
Semaglutide May Aid Vascular Repair in High-Risk Patients
Added: 2 months ago Source:  Radcliffe CVRM
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are known to reduce major atherosclerotic cardiovascular events, but the full extent of their mechanisms is still being explored. The SEMA-VR CardioLink-15 trial investigated whether semaglutide affects the levels of circulating vascular regenerative (VR) cells, which are involved in vessel repair and may modulate atherothrombotic risk.¹… View more

Cardiovascular Kidney Metabolic
LINC 25: The PATCH Study
Author(s): Sean Lyden Added: 1 year ago
LINC Conference 2025 - 30 day results of the PATCH study suggests the PerQSeal vascular closure device (Vivasure Medical Limited) can be used as an alternative percutaneous procedure for large-bore common femoral access, showing low risk of haematoma and a medium time of 0 minutes to achieve vessel closure.Dr Sean Lyden (Cleveland Clinic, Cleveland, OH, US) joins us to discuss the PATCH single… View more

Intervention

Vascular Disease and Surgery
DynamX Performance in Complex Coronaries: OCT Study
Author(s): Arif Al Nooryani , Ahmed Khashaba , George Sianos , et al Added: 3 weeks ago

Imaging & Diagnostics

Intervention
EHRA 24: The Style-AF Study
Author(s): Roland R Tilz Added: 2 years ago
EHRA 24 - We are joined onsite by Dr Roland Tilz (University Heart Center, DE) to discuss the findings of the Style-AF study (NCT05563142).This prospective, randomized, controlled study aims to compare the safety and efficacy of the Perclose ProStyle suture-medicated closure device to manual compression for the treatment of hemostasis after single-shot-device pulmonary vein isolation (PVI). 125… View more

Vascular Disease and Surgery

Electrophysiology & Arrhythmia
Retinal Vascular Density Linked to Subclinical Coronary Atherosclerosis
Added: 7 months ago Source:  Radcliffe Cardiology
A new study suggests that the health of the retinal microvasculature could serve as an indicator for subclinical coronary atherosclerosis in asymptomatic individuals with elevated cardiovascular risk. The findings, published in JAMA Cardiology, show a significant association between reduced retinal vascular density, measured by optical coherence tomography angiography (OCTA), and the presence and… View more

Demographic

Imaging & Diagnostics
Comparison of Haemodynamic Responses to Landiolol Versus Esmolol
Author(s): Georgios Koukoulitsios , Kyriaki Tsikritsaki , Georgios Magklaras , et al Added: 12 months ago

Vascular Disease and Surgery

Heart Failure